New drug trial aims to tame painful, recurring heart inflammation

NCT ID NCT07010159

Recruiting now Disease control Sponsor: Kiniksa Pharmaceuticals International, plc Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called KPL-387 to see if it can effectively treat and prevent the return of recurrent pericarditis, a painful inflammation of the heart's lining. It will involve about 165 adults who continue to have flare-ups despite standard treatments. The research aims to find the best dose, confirm the drug's effectiveness, and understand its long-term safety and ability to keep the condition under control.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Investigational Site 001
RECRUITING

Columbus, Georgia, 31904, United States
Investigational Site 002
RECRUITING

Overland Park, Kansas, 66221, United States
Investigational Site 003
RECRUITING

Cleveland, Ohio, 44195, United States
Investigational Site 004
RECRUITING

Chicago, Illinois, 60611, United States
Investigational Site 005
RECRUITING

Austin, Texas, 78705, United States
Investigational Site 006
RECRUITING

Charlottesville, Virginia, 22903, United States
Investigational Site 007
RECRUITING

Milan, 20157, Italy
Investigational Site 008
RECRUITING

San Francisco, California, 94158, United States
Investigational Site 009
RECRUITING

Cincinnati, Ohio, 45219, United States
Investigational Site 010
RECRUITING

Barcelona, 8035, Spain
Investigational Site 011
RECRUITING

Murcia, 30120, Spain
Investigational Site 012
RECRUITING

Rochester, Minnesota, 55905, United States
Investigational Site 013
RECRUITING

Houston, Texas, 77030, United States
Investigational Site 014
RECRUITING

Indianapolis, Indiana, 46184, United States
Investigational Site 015
RECRUITING

New York, New York, 10016, United States
Investigational Site 016
RECRUITING

Westminster, Colorado, 80023, United States
Investigational Site 017
RECRUITING

Southampton, SO17 1BJ, United Kingdom
Investigational Site 018
RECRUITING

Gilbert, Arizona, 85297, United States
Investigational Site 019
RECRUITING

Poitiers, 86000, France
Investigational Site 020
RECRUITING

London, EC1A 7BE, United Kingdom
Investigational Site 021
RECRUITING

Paris, 75013, France
Investigational Site 022
RECRUITING

New York, New York, 10032, United States
Investigational Site 023
RECRUITING

Norfolk, Virginia, 23507, United States
Investigational Site 024
RECRUITING

Madrid, 28850, Spain
Investigational Site 025
RECRUITING

Belgrade, 11000, Serbia
Investigational Site 026
RECRUITING

Belgrade, 11040, Serbia
Investigational Site 027
RECRUITING

Ottawa, Ontario, K1N 6N5, Canada
Investigational Site 028
RECRUITING

Montpellier, 34090, France
Investigational Site 029
RECRUITING

Genoa, 16132, Italy
Investigational Site 030
RECRUITING

Los Angeles, California, 90048, United States
Investigational Site 031
RECRUITING

Warsaw, 02-507, Poland
Investigational Site 032
RECRUITING

Voula, 166 73, Greece
Investigational Site 033
RECRUITING

Udine, 33100, Italy
Investigational Site 034
RECRUITING

Athens, 115 28, Greece

Conditions

Explore the condition pages connected to this study.

PERICARDITIS PERICARDITIS ACUTE RECURRENT PERICARDITIS